Invention Grant
US09580424B2 Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
有权
反式-7-氧代-6-(磺酰氧基)-1,6-二氮杂双环[3,2,1]辛烷-2-甲酰胺钠盐的结晶形式
- Patent Title: Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt
- Patent Title (中): 反式-7-氧代-6-(磺酰氧基)-1,6-二氮杂双环[3,2,1]辛烷-2-甲酰胺钠盐的结晶形式
-
Application No.: US14711162Application Date: 2015-05-13
-
Publication No.: US09580424B2Publication Date: 2017-02-28
- Inventor: Mahendra G. Dedhiya , Sisir Bhattacharya , Véronique Ducandas , Alexandre Giuliani , Valérie Ravaux , Alain Bonnet , Alain Priour , Peter Spargo
- Applicant: Forest Laboratories Holdings Limited
- Applicant Address: BM Hamilton
- Assignee: Forest Laboratories Holdings Limited
- Current Assignee: Forest Laboratories Holdings Limited
- Current Assignee Address: BM Hamilton
- Agent Andrew C. Chien; Matthew O. Brady
- Priority: FR0904864 20091009
- Main IPC: C07D471/08
- IPC: C07D471/08 ; A61K31/439 ; A61K31/675
![Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt](/abs-image/US/2017/02/28/US09580424B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to novel crystalline forms of sodium salt of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide (e.g., NXL-104) thereof. The present invention relates to compositions comprising a crystalline form of sodium salt of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide (e.g., NXL-104) alone or in combination with an antibacterial agent (e.g., ceftaroline fosamil). Processes for the preparation of the crystalline forms and methods of treating bacterial infections by administering the crystalline forms alone or in combination with an antibacterial agent (e.g., ceftaroline fosamil) are also described.
Public/Granted literature
Information query